Related Experiment Video
Updated: Jan 28, 2026

Growth, Purification, and Titration of Oncolytic Herpes Simplex Virus
Published on: May 13, 2021
Oncolytic herpes simplex virus tumor targeting and neutralization escape by engineering viral envelope glycoproteins
Xiao-Qin Liu1,2,3,4, Hong-Yi Xin5, Yan-Ning Lyu6
1a Faculty of Medicine, The Second School of Clinical Medicine , Yangtze University, Nanhuan , Jingzhou , Hubei , China.
Abstract:
Oncolytic herpes simplex viruses (oHSVs) have been approved for clinical usage and become more and more popular for tumor virotherapy. However, there are still many issues for the oHSVs used in clinics and clinical trials. The main issues are the limited anti-tumor effects, intratumor injection, and some side effects. To overcome such challenges, here we review the genetic engineering of the envelope glycoproteins for oHSVs to target tumors specifically, and at the same time we summarize the many neutralization antibodies against the envelope glycoproteins and align the neutralization epitopes with functional domains of the respective glycoproteins for future identification of new functions of the glycoproteins and future engineering of the epitopes to escape from host neutralization.
Insights
Oncolytic herpes simplex viruses (oHSVs) show promise in tumor virotherapy but face challenges. Genetic engineering of oHSV envelope glycoproteins can improve tumor targeting and overcome limitations for enhanced cancer treatment.
Area of Science:
- Oncology
- Virology
- Genetic Engineering
Background:
- Oncolytic herpes simplex viruses (oHSVs) are increasingly used for tumor virotherapy.
- Clinical applications face challenges including limited efficacy, need for intratumor injection, and side effects.
Purpose of the Study:
- To review genetic engineering strategies for oHSV envelope glycoproteins.
- To summarize neutralization antibodies targeting oHSV envelope glycoproteins.
- To align neutralization epitopes with functional domains for future engineering.
Main Methods:
- Literature review of genetic engineering approaches for oHSVs.
- Analysis of neutralization antibodies and their target epitopes on oHSV envelope glycoproteins.
- Mapping of epitopes to functional domains of glycoproteins.
Main Results:
- Genetic engineering offers potential for specific tumor targeting by oHSVs.
- Neutralization antibodies target specific epitopes on oHSV envelope glycoproteins.
- Understanding epitope-domain relationships is key for future oHSV development.
Conclusions:
- Engineering oHSV envelope glycoproteins can enhance tumor specificity and efficacy.
- Knowledge of neutralization epitopes aids in designing oHSVs that evade host immune responses.
- Further research into glycoprotein engineering can overcome current limitations in oHSV therapy.
Related Concept Videos
Viral Structure
What are Viruses?
Viral Recombination
Escape Velocity
To calculate the escape velocity, it is assumed that no energy is lost to any frictional forces. In practice, a satellite...
Outer Layers of the Cell Envelope
Escape Velocities of Gases

